China begins long march to epilepsy control

Lancet Neurology

Volumn 2, Issue 9, 2003, Pages 525-

  Pal, Deb K ^a  

^a Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEREBROVASCULAR DISEASE; CHINA; COST BENEFIT ANALYSIS; EPILEPSY; HEAD INJURY; HEALTH CARE COST; HEALTH CARE SYSTEM; HEALTH PROGRAM; HUMAN; INFECTION CONTROL; NEUROCYSTICERCOSIS; NOTE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; TUBERCULOSIS;

EID: 0043022089     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(03)00496-4     Document Type: Letter

References (5)

1. Wang W.Z., Wu J.Z., Wang D.S., et al. The prevalence and treatment gap in epilepsy in China. Neurology. 60:2003;1544-1545.
2. Li S.C., Schoenberg B.S., Wang C.C., Cheng Z.M., Zhou S.S., Bolis C.L. Epidemiology of epilepsy in urban areas of the people's republic of China. Epilepsia. 26:1985;391-394.
3. Xianyi C., Fengzeng Z., Hongjin D., et al. The DOTS strategy in China: results and lessons after 10 years. Bull World Health Organ. 80:2002;430-436.
4. Tuberculosis in China: interview with Richard Harris. New York: National Public Radio, June 6, 2003.
5. Pal DK. Shadows and Light. Childhood epilepsy as a public health priority: Indian perspectives. Discussion paper for UKDepartment for International Development of Improved Care for Diseases of Children Work Program, May 2002. http://www.ich.ucl.ac.uk/ich/html/academicunits/int_p_c/pdfs/Shadows&Light. pdf (accessed Aug 1, 2003).